Bonfiglioli Transmissions
FINAL DAY — best accounts here, and the book is the question15–19 Oct · CLOSES TODAY · lists ~24 Oct · band ₹558–586 · ~₹2,534 Cr · 100% OFS by the Italian parent
PAT +29.2% to ₹148.58 CrDEBT-FREE, no borrowings since CY24ROCE 24.53% → 34.05%H1 FY27 EBITDA ₹223.87 Cr vs ₹176.43 Crbook doubled 0.48× → 0.99×retail 1.16× — allotment still near-certainQIB 0.16× with one session leftGMP 30.4% → 23.9% → 22.2%100% OFS — the parent is selling
- FY26 PAT
- ₹148.58 Cr (+29.2%)
- ROCE
- 34.05%
- P/E upper
- ~46.3×
- day 1
- 0.48×
- day 3
- 0.99×
- QIB
- 0.16×
- retail
- 1.16×
- GMP 15 Oct
- 30.4%
- GMP today
- 22.2%
<strong>The accounts have not moved all week and the book has barely cleared one times.</strong> Profit up 29.2%, no borrowings since CY24, return on capital from 24.53% to 34.05%, H1 FY27 EBITDA already ahead of last year — and 0.99× on day three with institutions at 0.16×. <strong>The footnote argues this is not yet a verdict, and the evidence is on this same board.</strong> HD Fire was at QIB 1.49× with one session left and closed at 256.65×. Institutions bid last. So the number that matters is tonight’s, not Friday’s. <strong>For a retail applicant the weak book remains an advantage.</strong> Retail at 1.16× means a lot is close to certain, the inverse of HD Fire’s one-in-thirty. That is what this application is: not a lottery ticket on a pop, but the one name on this board worth owning after it lists. <strong>Apply for the business. Do not count on the pop, and be willing to be refunded if the book does not close.</strong>
Tonbo Imaging India
AVOID STANDS — final day, and the call is losing badly15–19 Oct · CLOSES TODAY · band ₹665–700 · ₹852.18 Cr · 100% OFS — the company receives nothing
7.78× with a session still to runNII 14.35× — more than doubled overnightthe only premium that has risen all weekrevenue −22.7% in FY26PAT −30% in FY26Q1 FY27 a ₹17.74 Cr LOSSnegative operating cash flow FY25 AND FY26working capital 152 → 280 → 517 days~79× earnings that are falling
expected listing~+72% implied
- GMP 12 Oct
- 38.6%
- GMP 15 Oct
- 71.4%
- GMP today
- 74.3%
- day 2 book
- 4×
- day 3 book
- 7.78×
- QIB
- 3.95×
- NII
- 14.35×
- FY26 revenue
- ₹362.65 Cr (−22.7%)
- Q1 FY27
- −₹17.74 Cr
- WC days
- 517
<strong>The book nearly doubled again and the premium rose for the fifth session running.</strong> 7.78× overall, NII 14.35×, QIB 3.95× — on a company whose revenue fell 22.7%, whose profit fell 30%, which lost ₹17.74 Cr in the first quarter of the year being sold, whose operating cash flow was negative in both FY25 and FY26 while profits were reported, and whose working capital runs to 517 days. The company receives none of the ₹852 Cr. <strong>This page said avoid on 13 October at 61%. It is 73.7% now.</strong> The call is unchanged and it is losing. It is recorded here, before the print, for the same reason it was recorded then: the only version of this page worth keeping is one where a wrong call stays wrong on the record.
HD Fire Protect
LISTS TUESDAY — sell on listing13–15 Oct · allotted · LISTS 21 OCT · band ₹258–271 · ₹712.31 Cr, entirely OFS · 100% OFS — both sellers are the promoters
QIB 256.65× finalanchor FULL at the top band, 71.88% domestic MFsRoE 30.17%, RoCE 40.33%retail 30.49× — most applicants got nothing40.7× for 6.4% PAT growth
- QIB
- 256.65×
- NII
- 203.21×
- retail
- 30.49×
- GMP
- ₹85 · 31.4%
- P/E post
- 40.7×
- lists
- 21 Oct
<strong>The one call on this board that has gone exactly as written.</strong> On 15 October this page flagged QIB at 1.49× as the issue’s only soft spot and said institutions bid on the final day; the book closed at 256.65×, and the 16th recorded that the worry had been wrong. Nothing has changed in the accounts — 40.7 times for 6.4% growth, every rupee to the promoters — so the plan is the plan: <strong>sell into the listing on Tuesday.</strong> A 31.4% premium implies about +29% after the overstatement this page applies, and a book this size means most retail applicants are holding nothing to sell.
Zetwerk
NO — the premium has collapsed to almost nothing15–19 Oct · CLOSES TODAY · band ₹151 · ~₹5,000 Cr · ₹2,600 Cr fresh + 9.68 Cr OFS
GMP 15.2% → 9.9% → 4.6% → 3.3%under +1% after the measured overstatementFY26 LOSS of ₹1,606.17 Crthe only issue raising real moneyorder book ₹13,062 Cr, 1.39× revenueno exchange book — demand unverified
- GMP 15 Oct
- 15.2%
- GMP 16 Oct
- 9.9%
- GMP today
- 3.3%
- FY26 income
- ₹16,100.63 Cr
- FY26 result
- −₹1,606.17 Cr
- order book
- ₹13,062.40 Cr
<strong>Two thirds of the premium is gone in four sessions</strong> — 15.2% to 9.9% to 4.6% — and at 4.6%, after the 2.6-point overstatement this page applies to every GMP, the expectation is about two per cent. That is not a listing trade; it is a coin toss with costs. Nothing in the filings changed: ₹16,100.63 Cr of income for a ₹1,606.17 Cr loss, a real ₹13,062 Cr order book, and a manufacturing margin improving from 4.83% to 6.56%. A business that must triple its margin to break even was never a listing-day trade, and the grey market has now stopped pretending otherwise.
Sahajanand Medical
THIN — final day, premium still fading15–19 Oct · CLOSES TODAY · band ₹344 · OFS · OFS
PAT ₹25.15 Cr → ₹69.08 Crrevenue +18.11% to ₹1,210.50 CrGMP 13.1% → 10.2% → 7.3%~53× FY26 diluted73.87% of revenue earned outside Indiano exchange book — demand unverified
- FY26 revenue
- ₹1,210.50 Cr (+18.11%)
- FY26 PAT
- ₹69.08 Cr (was ₹25.15 Cr)
- P/E
- ~53×
- GMP 16 Oct
- 13.1%
- GMP today
- 7.3%
<strong>The better business of the two closing quietly tonight, and the market is not paying for it.</strong> Profit from ₹25.15 Cr to ₹69.08 Cr, revenue up 18.11%, cardiac implants sold into 77 countries — priced at roughly 53 times for that near-tripling to continue, with 73.87% of revenue earned abroad carrying the currency with it. The premium has eased from 13.1% to 10.2% and no exchange book has matched, so the demand side is unverified and the premium is the only signal available. It is also the signal this page trusts least. Eight per cent expected, on an unverified book, is a thin edge.
Jio Platforms
OPENS WEDNESDAY — read the prospectus before it does21–23 Oct · lists 28 Oct · band ₹1,065–1,119 · ~₹30,000 Cr (27 Cr fresh shares) · Fresh issue
the largest IPO this market has listedfresh issue — the money goes into the companyGMP firming, 20.6% → 20.1% → 22.3%size alone makes a large pop unlikely
- band
- ₹1,065–1,119
- size
- ~₹30,000 Cr
- lot
- 12 sh · ₹13,428
- GMP 16 Oct
- 20.6%
- GMP today
- 22.3%
- opens
- 21 Oct
- lists
- 28 Oct
<strong>Still no call, and the prospectus gets read before there is one.</strong> The premium has held near 20% for a week, which after the measured overstatement implies about +18%, and the issue is fresh capital rather than an exit — the only one of the week that can say so besides Zetwerk. <strong>Its shadow over this week is the thing to carry forward.</strong> A ₹30,000 Cr call on the market two days out remains the most plausible reason Bonfiglioli’s institutional book sat at 0.16× on Friday. If that is right, tonight’s Bonfiglioli close should still be weak and that will be an argument about liquidity rather than about the company.
Paras Healthcare
OPENS WEDNESDAY — no call yet21–23 Oct · band up to ₹693 · ₹1,800 Cr · ₹500 Cr fresh + ₹1,300 Cr OFS
₹500 Cr is fresh capital₹1,300 Cr of ₹1,800 Cr is a seller exitingGMP 14.4% → 13.7%opens the same morning as Jio
- band
- up to ₹693
- size
- ₹1,800 Cr
- fresh
- ₹500 Cr
- OFS
- ₹1,300 Cr
- GMP 16 Oct
- 14.4%
- GMP today
- 13.7%
<strong>A hospital chain raising ₹1,800 Cr, of which ₹1,300 Cr is a shareholder leaving.</strong> The accounts get read properly before Wednesday rather than summarised from a price band here. The timing remains the first thing to say about it: it opens on the same morning as a ₹30,000 Cr issue, and the 13.7% premium — easing, not firming — is being quoted into that.